P
Probiotix Health PLC
F:X90
Probiotix Health PLC
F:X90
Price:
0.068
EUR
Market Closed
Market Cap:
€13.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Probiotix Health PLC
F:X90
|
UK |
|
ICON PLC
NASDAQ:ICLR
|
IE |
|
Focus Financial Partners Inc
F:2JE
|
US |
|
L
|
Loxley PCL
SET:LOXLEY
|
TH |
|
B
|
Belships ASA
XBER:NS6
|
NO |
|
T
|
Thang Long Joint Stock Corp
VN:TTL
|
VN |
|
Biora Therapeutics Inc
NASDAQ:BIOR
|
US |
|
IDT Australia Ltd
ASX:IDT
|
AU |
|
Arezzo Industria e Comercio SA
BOVESPA:ARZZ3
|
BR |
|
One REIT Inc
TSE:3290
|
JP |
|
Nihon Jyoho Create Co Ltd
TSE:4054
|
JP |
|
A
|
Asiainfo Security Technologies Co Ltd
SSE:688225
|
CN |
|
Chennai Petroleum Corporation Ltd
NSE:CHENNPETRO
|
IN |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
Multiples-Based Value
The Multiples-Based Value for Probiotix Health PLC (X90) under the Base Case is hidden EUR. Compared with the current market price of 0.068 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
X90 Multiples-Based Value
LOCKED
Multiples Across Competitors
X90 Competitors Multiples
Probiotix Health PLC Competitors
Probiotix Health PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
P
|
Probiotix Health PLC
F:X90
|
13.9m EUR | 5.4 | -16.4 | -15.2 | -14.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
